1. Zhu, Ying, Sun, Xiwen, Tan, Shaolin, Lin, Hai, Zhang, Weitian. 2022. M2 macrophage-related gene signature in chronic rhinosinusitis with nasal polyps. In Frontiers in immunology, 13, 1047930. doi:10.3389/fimmu.2022.1047930. https://pubmed.ncbi.nlm.nih.gov/36466903/
2. You, GuoHua, Zhao, XueGang, Liu, JianRong, Sui, Xin, Yi, HuiMin. 2023. Machine learning-based identification of CYBB and FCAR as potential neutrophil extracellular trap-related treatment targets in sepsis. In Frontiers in immunology, 14, 1253833. doi:10.3389/fimmu.2023.1253833. https://pubmed.ncbi.nlm.nih.gov/37901228/
3. Uchiyama, Toru, Kawai, Toshinao, Nakabayashi, Kazuhiko, Nunoi, Hiroyuki, Onodera, Masafumi. 2023. Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 3424-3440. doi:10.1016/j.ymthe.2023.09.004. https://pubmed.ncbi.nlm.nih.gov/37705244/
4. Beaumel, Sylvain, Verbrugge, Lucile, Fieschi, Franck, Stasia, Marie José. . CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation. In Clinical and experimental immunology, 212, 156-165. doi:10.1093/cei/uxad028. https://pubmed.ncbi.nlm.nih.gov/36827093/
5. Rawat, Amit, Bhattad, Sagar, Singh, Surjit. 2016. Chronic Granulomatous Disease. In Indian journal of pediatrics, 83, 345-53. doi:10.1007/s12098-016-2040-3. https://pubmed.ncbi.nlm.nih.gov/26865172/